In vitro efficacy of triclosan coated polyglactin 910 suture against common bacterial pathogen causing surgical site infection
AbstractSurgical-site infections (SSIs) increase morbidity and mortality in post-surgical patients as well as represent an economic burden to healthcare systems. The aim of this study was to evaluate the in-vitro efficacy of triclosan coated polyglactin 910 suture against the common bacteria isolated from post-operative wound infection. Our goal was to establish whether the use of a triclosan coated suture would reduce the incidence of microbial colonization of suture material thus reducing the rate of surgical site infection. Similar length of triclosan coated and uncoated sutures were put on the lawn culture made on Mueller Hinton agar by 0.5 McFarland standard suspensions prepared by touching 4-5 colonies of each bacterium isolated from post-operative wound infections. After overnight incubation at 370C, the zone of inhibition around triclosan coated sutures was compared to the zone of inhibition that was found around uncoated sutures. Among 271 (81.87%) positive cultures from 331 post-operative wound samples, the commonest bacterial isolates were S. aureus (29.52%), followed by E.coli (17.34%), Klebsiella (15.13%), Coagulase negative Staphylococcus (9.96%), Pseudomonas (9.22%), Proteus (6.64%), Enterococcus (5.53%), Citrobacter (3.69%), and Acinetobacter spp.(2.95%). We found that after overnight incubation at 370C, a good zone of inhibition was present around triclosan coated sutures in all isolates except Pseudomonas and Enterococcus spp. – but minimal or no such zone was found around uncoated sutures. Triclosan coated suture can significantly reduce the SSI rate, cost and duration of hospital stay and it is highly effective against the common bacteria isolated from post-operative wound infection.
Copyright conditions: Copyright on any research article in the International Journal of Infection Control (IJIC) is retained by the author(s). Authors grant IJIC permission to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. IJIC conforms to the Creative Commons Attribution License (http://creativecommons.org) as terms and conditions of publishing research articles. In summary, anyone is free: • to copy, distribute, and display the work; • to make derivative works; • to make commercial use of the work; as long as: • the original author must be given credit; • for any reuse or distribution, it must be made clear to others what the license terms of this work are; • any of these conditions can be waived if the authors gives permission. Statutory fair use and other rights are in no way affected by the above. Authors' certification: In submitting a manuscript to IJIC, authors are requested to certify that: • They are authorized by their co-authors to enter into these arrangements. • They warrant, on behalf of themselves and their co-authors, that: o the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights; o they are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to IJIC are not in breach of any other obligation. If the law requires that the article be published in the public domain, they will notify IJIC at the time of submission; o the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy; o they have taken due care to ensure the integrity of the article.